SavedAdd your journal

Journals / Records of Natural Products / 2021 / Cilt: 15 - Sayı: 3

Phytochemistry, Pharmacological Potency, and Potential Toxicity of Myoporum spp.

Arafa MUSA
Pages
148–168
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The present review aims to explore the phytochemistry, beneficial uses and the toxic potentials of Myoporum spp.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Genus Myoporum family Myoporaceae, includes approximately 32 species of woody small trees or shrubs, most of them are native to Australia and surrounding territories.
📊
Key Findings & Data:Only certain species have been thoroughly studied and rich in flavonoids, phenylethanoids, Phenylpropanoids, terpenoids, iridoids, essential oil, and trace alkaloids.
💡
Conclusion & Impact:The present review aims to explore the phytochemistry, beneficial uses and the toxic potentials of Myoporum spp.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Genus Myoporum family Myoporaceae, includes approximately 32 species of woody small trees or shrubs, most of them are native to Australia and surrounding territories. Only certain species have been thoroughly studied and rich in flavonoids, phenylethanoids, Phenylpropanoids, terpenoids, iridoids, essential oil, and trace alkaloids. The essential oils are characterized by sesquiterpenes type components, either in ketone or alcoholic forms usually combined to a furanoid moiety. Myoporum spp. have been utilized in folk medicine for treatment of various diseases and were used as antidermatitis, antibacterial, antipyretic, anti-pulpitis, antipsychotic, anti-inflammatory, detoxicant, and others. Despite all these benefits, Myoporum spp. must be cautiously employed due to their potential toxicities, which arise from the presence of furanosesquiterpenoid contents, particularly in their essential oil. The toxicity influences liver and can extend to kidney and lung causing injury. The present review aims to explore the phytochemistry, beneficial uses and the toxic potentials of Myoporum spp.

🔖

Cite This Article

MUSA, A. (2021). Phytochemistry, Pharmacological Potency, and Potential Toxicity of Myoporum spp.. Records of Natural Products, Cilt: 15 - Sayı: 3, 148–168. https://ajindex.com/articles/308219

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. E. L. Ghisalberti (1995). The chemistry of unusual terpenoids from the genus Eremophila, in Studies in Natural Products Chemistry 15, ed: Elsevier, pp. 225-287
  2. T. G. Tutin, V. H. Heywood, N. A. Burges and D. H. Valentine (1964). Flora Europaea: Plantaginaceae to Compositae (and Rubiaceae), 4, ed: Cambridge University Press, 190
  3. B. Dinda (2019). Pharmacology and applications of naturally occurring iridoids: Springer, Switzerland
  4. R. J. Chinnock (2007). Eremophila and allied genera: a monograph of the plant family Myoporaceae, 1st ed., Rosenberg Publishing, Dural, N.S.W. 80-158
  5. G. L. Webster (1951). The Polynesian species of Myoporum, Pac. Sci. 5(1), 55-77
  6. S. Carlquist and D. A. Hoekman (1986). Wood anatomy of Myoporaceae: ecological and systematic considerations, Aliso: J. System. Evolut. Bot. 11, 317-334
  7. E. L. Ghisalberti (1993). The phytochemistry of the Myoporaceae, Phytochemistry 35, 7-33
  8. G. S. Richmond and E. L. Ghisalberti (1995). Cultural, food, medicinal uses and potential applications of Myoporum species (Myoporaceae), Econom. Bot. 49, 276-285
  9. L. A. Mound and D. C. Morris (2007). A new thrips pest of Myoporum cultivars in California, in a new genus of leaf-galling Australian Phlaeothripidae (Thysanoptera), Zootaxa 1495, 35-45
  10. C. Shogren (2017). Myoporum thrips life history, Doctoral dissertation, host preference, and biological control, University of California, Riverside
  11. S. M. Walters and J. Cullen (1984). The European garden flora: a manual for the identification of plants cultivated in Europe, both out-of-doors and under glass, 6(4), Cambridge University Press, 412
  12. T. Iwashina and G. Kokubugata (2010). Flavonoids in the leaves and flowers of Myoporum bontioides native to northernmost region in the Myoporaceae, Bull. Natl. Sci. Mus. Ser. B, 36, 117-125
  13. C. Menut, P. Cabalion, E. Hnawia, H. Agnaniet, J. Waikedre and A. Fruchier (2005). Two new furanosesquiterpenes from Myoporum crassifolium from New Caledonia, Flav. Fragr. J. 20, 621-625
  14. J. G. Tan, W. Dong and L.X. Qiaolin (2019). Preparation of new alkaloids as antibacterial agent for methicillin-resistant Staphylococcus aureus, China Patent CN 109553565
  15. H. Grant, P. O'Regan, R. Park and M. Sutherland (1980). Terpenoid chemistry. XXIV.(1R)-1- methoxymyodesert-3-ene, an iridoid constitutent of Myoporum deserti (Myoporaceae), Aust. J. Chem. 33, 853-878
  16. H. Grant, C. Russell-Maynard and M. Sutherland (1985). Terpenoid